1.Management of Children with Neutropenic Fever.
Korean Journal of Pediatrics 2004;47(Suppl 2):S490-S509
3.Exercise induced heat stroke and acute renal failure.
Korean Journal of Medicine 2002;62(4):365-368
No abstract available.
Acute Kidney Injury*
;
Heat Stroke*
;
Hot Temperature*
4.Job Stress and Cardiovascular Disease.
Journal of the Korean Academy of Family Medicine 2002;23(7):841-854
No absteact available.
Cardiovascular Diseases*
5.The Methods and Ethical Problems in the Human Clone.
Journal of the Korean Medical Association 1997;40(9):1146-1153
No abstract available.
Clone Cells*
;
Humans*
6.Management of low back pain in primary care.
Journal of the Korean Academy of Family Medicine 2000;21(5):586-599
No abstract available.
Low Back Pain*
;
Primary Health Care*
7.Correction: Value of Analog in Medicine: Digital Compromise to Teach Old-Timer New Trick.
Healthcare Informatics Research 2015;21(4):324-324
This note corrects an error in title.
9.Medical Trerapy of Erectile Dysfunction.
Journal of the Korean Medical Association 2002;45(9):1149-1160
Sexual function is and important component of an individual's quality of life and subjective well being. In the field of erectile dysfunction (ED), we have witnessed the introduction of truly effective oral pharmacotherapy for this disorder. The marketing of the first oral phosphodiesterase (PDE) inhibitor (sildenafil, viagra®) in 1998 increased the public's awareness about sexual dysfunction and enlightened their perceptions about ED as a medical condition with distinct risc factors. Sildenafil has shown excellent effects in the treatment of ED patients with or without cardiovascular disease although the agent is contraindicated in patients taking nitrates. Sublingual (SL) apomorphine (uprima®) is a nonopioid, centrally acting dopamine agonist developed to treat ED. Three milligrams of SL apomorphine SL 3㎎ has significant benefit for men with ED as measured by all currently acceptable erectile function endpoints of 'erections firm enough for intercourse'. Self-injection therapy (alprostadil, caverject® or trimix) is a very effective treatment option. In a short time, multiple agents (vardenafil, tadanafil, et al.) will be developed and introduced for management of ED. The impending approval of new treatment for ED will bring a plethora of choices for the physician treating ED. Primary care physicians will look to urologists as the experts in ED for information and guidance on which medication to use. It is therefore important that we keep abreast of developments in this rapidly evolving field of sexual medicine.
Apomorphine
;
Cardiovascular Diseases
;
Dopamine Agonists
;
Drug Therapy
;
Erectile Dysfunction*
;
Humans
;
Male
;
Marketing
;
Nitrates
;
Physicians, Primary Care
;
Quality of Life
;
Sildenafil Citrate
10.Chronic Prostatitis Patient with Seminal Vesiculitis and Elevated PSA.
Journal of the Korean Medical Association 2000;43(6):575-581
No abstract available.
Humans
;
Prostatitis*
Result Analysis
Print
Save
E-mail